Molecular impact of mutations in RNA splicing factors in cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Somatic mutations in RNA splicing machinery components are frequent in various cancers.
• Key mutated splicing factors include SF3B1, U2AF1/2, SRSF2, and RBM10, impacting splice site recognition.
• Emerging evidence suggests small nuclear RNAs (snRNAs) may also contribute to splicing dysregulation in cancer.

Purpose of the Study:

• To elucidate the molecular mechanisms by which mutations in RNA splicing factors alter splice site recognition.
• To explore how these alterations provide insights into cancer pathogenesis.
• To discuss the link between mutant splicing factors and broader RNA metabolism.

Main Methods:

• Analysis of molecular mechanisms of splice site recognition.
• Review of studies on cancer pathogenesis related to splicing factor mutations.
• Examination of data linking mutant splicing factors to RNA metabolism.

Main Results:

• Mutations in splicing factors like SF3B1 and U2AF1/2 directly affect branch site and 3' splice site recognition.
• These mutations lead to altered RNA splicing patterns.
• Mutant splicing factors are implicated in RNA metabolism beyond their canonical splicing roles.

Conclusions:

• Mutations in RNA splicing factors are a significant driver of cancer development.
• Understanding these splicing alterations provides crucial insights into cancer pathogenesis.
• Mutant splicing factors have roles extending to other aspects of RNA metabolism.